British scientists have developed a new medicament for breast cancer

British scientists have developed a new medicament for breast cancer

Recently at a medical conference in Chicago British researchers have shown a new chemical called eribulin. Eribilin is natural compound obtained from marine sponge. Clinical and laboratory analyses showed that eribulin can help to prolong the life of women suffering from breast cancer at late stage. Previously eribulin was known as  E7389 or  NSC-707389 and is being investigated by Eisai Co.

Eribulin is a synthetic macrocyclic ketone being analogue of the marine sponge - natural product  halichondrin B The scientists showed that Eribulin mimics a component that prevents cell division of sponges. This unique action mechanism was found in Halichondria genus of sponges. The scientists showed that patients treated by chemotherapy and eribulin, lived 2-3 months longer than those receiving only chematherapeutic medicines.

Researchers from Britain's Leeds University say that this is the first standard form of therapy for patients receiving all possible treatments, including radiation.



Feb 23, 2014